20/20 Onsite earned site readiness certification, providing mobile option for clinical trials
The certification will allow 20/20 Onsite to make clinical trials more accessible to patients nationwide and expand site options for sponsors while maintaining performance and data collection standards, including BCVA and DR testing.
The certification will allow 20/20 Onsite to make clinical trials more accessible to patients nationwide and expand site options for sponsors while maintaining performance and data collection standards, including BCVA and DR testing. (Image Credit: Adobe Stock/rohane)
20/20 Onsite has earned a Site Readiness Certification from Precision Vision Clinical Trial Solutions, a division of Precision Vision, the first mobile clinic to do so, according to the press release.1 This certification allows study sponsors to feel confident that 20/20 Onsite has the required equipment and clinical staff to accurately perform and collect data in support of their primary endpoints.
This certification indicates that 20/20 Onsite’s examination lane onboard its Mobile Vision Clinic meets the requirements to perform BCVA assessments, including the proper distance for early treatment diabetic retinopathy study (ETDRS) equipment and fully controllable lighting conditions throughout the vehicle. With this, 20/20 Onsite cements its commitment to reducing burdens for sponsors and research sites while making clinical trials more accessible to participants nationwide.
Adam Merola, Director of Life Sciences at 20/20 Onsite, shared his gratitude for this certification and hope for the company’s future in the press release. “We are grateful for our partnership and endorsement from Precision Vision. Being certified by the manufacturer of the vision testing equipment already onboard our Mobile Vision Clinic allows us to continue delivering exceptional clinical vision care and make it easier for sponsors who have best-corrected visual acuity requirements in their study to partner with us.”
Precision Vision supports vision research trials by manufacturing the equipment required for BCVA testing. Its Clinical Trials Solutions division is led with over 20 years of experience in ophthalmic research and BCVA certification.
Melissa Cowen, Head of Clinical Trial Solutions at Precision Vision, spearheaded the certification process onboard the Mobile Vision Clinic and commended the ease of working with 20/20 Onsite. She is quoted in the press release saying, “The 20/20 Onsite mobile unit is staffed with professionals who are knowledgeable and proactively prepared for various assessments that may need to be performed to support the study endpoint,” Cowen said. “Their novel approach of bringing research to the subject will expand clinical trial participation to subjects in geographic areas not typically served by studies.”
The Site Readiness Certification joins 20/20 Onsite’s growing list of qualifications for its fleet of Mobile Vision Clinics, including an ophthalmic certification from Emmes Optym and an excellent air quality certification from STERIS.
“Our clients benefit from the assurance provided by our staff and site being pre-certified by multiple reputable organizations,” Merola added. “The Site Readiness Certification ensures our testing output is accurate and reliable, giving our clients the utmost confidence in the results we deliver.”
